Sinclair finds new CEO to lead hunt for acquisitions

Hot on the trail of new acquisitions, the UK's Sinclair Pharma says it struck a deal to buy two burn creams from Solvay and has found a new CEO to replace Michael Flynn, who is retiring. Christopher Spooner, who founded HealthCor Management UK, is taking his spot as the company lays plans for more deals. "There are other things we're looking at... we'd like to move to the point where we have four or five key brands developing steady revenues for us," Chief Financial Officer Jerry Randall told Reuters. Report

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.